- $883.39m
- $813.37m
U.S. STOCKS ON THE MOVE-Keysight Technologies, BILL Holdings, Hawaiian Electric
Alpha Tau Medical rises on long-term data for its cancer therapy
Brief: Alpha Tau Announces Robust Long-Term Safety And Efficacy Data From Multiple Clinical Trials Of Alpha Dart
Brief: Alpha Tau Medical Reports Q1 Net Loss Per Share Of $0.12
Brief: Alpha Tau Expands Its Alpha Dart Treatment To Vulvar Cancer In Novel Clinical Trial With Cambridge University
Brief: Alpha Tau Announces The Publication Of Its US Multicenter Pilot Skin Cancer Trial Results In Jama Network Open
Brief: Alpha Tau Medical Confirms No Direct Exposure To Silicon Valley Bank
Brief: Alpha Tau Medical Announces Full Year 2022 Financial Results
Brief: Alpha Tau Announces Alpha DaRT Treatment Of First 2 Patients In Multicenter Recurrent Skin Cancer Trial
Brief: Alpha Tau Announces Grant Of Expanded Radioactive License And Final Pre-Clinical Laboratory Regulatory Approval At Its Jerusalem Headquarters
Brief: Alpha Tau Medical Announces Third Quarter 2022 Financial Results
Brief: Alpha Tau Medical Announces Second Quarter 2022 Financial Results
Brief: Alpha Tau And Mim Software Announce Collaboration For Alpha Dart Treatment Planning
Brief: Alpha Tau Announces Treatment Of First Prostate Cancer Patient With Alpha Dart
Brief: Alpha Tau Announces Receipt Of Radioactive License To Allow Production In Main Manufacturing Floor At Its Jerusalem Site, Amended Radioactive License With Increased Capacity At Lawrence, Ma Site
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:00 PM
Brief: Alpha Tau Announces FDA Approval Of Ide To Initiate Multi-Center Pivotal Study Of Alpha Dart
Brief: Alpha Tau Announces Resignation Of Gary Leibler From Its Board Of Directors
Brief: Alpha Tau Treats First Patients In France With Alpha DaRT As Part Of Skin Cancer Trial